On this page
Schistosomiasis is one of the neglected tropical diseases (NTDs) targeted for elimination by 2030 as part of the UN’s Sustainable Development Goal 3. A recent global interest in schistosomiasis is due to the impact it has on the reproductive system, particularly for women, when it is known as FGS. FGS has great public health implications and consequences for women and girls affected. The current strategy for the control of schistosomiasis focuses only on school-aged children (5 to 15 years), leaving out some girls who do not attend school and women of reproductive age (> 15). These women and girls are at an increased risk of FGS as they do not have access to treatment.
Nigeria’s current national guidelines for schistosomiasis control have no provision for management of FGS. Hence this study aimed to raise awareness about FGS among health workers at local facilities, and provide evidence-based information on how to detect and provide treatment care for those affected by FGS. This study was carried out in two local government areas (LGAs) in Ogun State (Abeokuta North and Odeda LGA), where cases of FGS have been confirmed.
A quality improvement (QI) process known as plan-do-study-act (PDSA) cycle was used to develop and pilot a diagnostic algorithm, treatment package and referral system for management of FGS within the health system structure. PDSA cycle involves health workers in assessing problems, suggesting solutions and piloting the intervention.
This step involved identifying a goal or purpose, formulating an intervention or improvement (in this case in the diagnosis, treatment and referral systems for FGS), and defining success metrics. It involved planning the intervention with a newly established FGS quality care implementation team who explored the challenges and barriers to diagnosis and treatment, and developed a diagnostic algorithm, treatment package and referral system for FGS.
This is the step in which the components of the plan are implemented. The study included a participatory workshop to educate and increase awareness of frontline health workers on FGS and build their capacity to be able to diagnose and provide the needed treatment for persons affected or refer them.
This step involved monitoring outcomes to test the validity of the plan for signs of progress and success, or problems and areas for improvement. This included evaluating the intervention and process (including interviews with health professionals and patients). The study included a review of the intervention process at four weeks initially and subsequently at 12 weeks and 24 weeks intervals to understand what is working well and address any barriers to the intervention. This was carried out through interviews with health workers and patients that access the care.
This step closed the cycle, integrating the learning generated by the entire process. All learnings at the different phases were collected together and used to improve the quality of the intervention approach. A final process evaluation was conducted at the end of project implementation.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.